Long-Term Outlook, Surgery, and Living with MCADD
At a Glance
With early diagnosis and consistent management, the long-term outlook for MCADD is excellent. Children can achieve normal growth and a healthy life by avoiding extreme fasting and utilizing IV 10% dextrose during surgeries or illness to prevent a metabolic crisis.
The most important thing to know about your child’s future is that early diagnosis has changed everything. Because your child was identified through newborn screening, they have a “head start” that previous generations did not [1]. With consistent management, the long-term outlook for a child with MCADD is excellent, and they are expected to grow up healthy, hit all their milestones, and lead a normal life [2][3].
The Long-Term Outlook
For most children with MCADD, the condition becomes a manageable part of their background rather than a defining feature of their lives.
- Normal Growth and Intelligence: Research shows that when metabolic crises are prevented, children with MCADD have normal neurological development and physical health [2][4].
- Lifelong Management: While the “danger zone” of frequent infant feedings passes, the core rule of avoiding extreme fasting remains for life [5].
- Adult Health: Most adults with MCADD live standard lives. Scientists are continuing to study the lipid metabolism of adults with MCADD to see if there are subtle long-term changes that might benefit from monitoring as they age [6].
Surgery and Medical Procedures
Surgery requires special planning because of the fasting (NPO) typically required for anesthesia. For a person with MCADD, a standard fast for surgery can be dangerous if not proactively managed [7].
- The Surgical Protocol: Current guidelines require that MCADD patients receive intravenous 10% dextrose (D10) fluids during any period they are required to fast for a procedure [7][8].
- Preventing a Crisis: This continuous IV sugar keeps the body in a “fed” state, preventing the metabolism from switching to burning fat and creating toxic byproducts while the patient is in the operating room [8].
- Monitoring: Doctors may use continuous glucose monitoring to ensure levels stay stable throughout the surgery and recovery [9].
Transitioning Through the Stages of Life
As your child grows, your role will shift from “manager” to “educator.”
- Childhood and School: Management focuses on ensuring teachers and coaches understand the need for regular snacks and how to spot signs of illness [3].
- Adolescence: This is a critical time for transition. Teenagers must learn why they cannot skip meals for weight loss and how to handle illness protocols on their own [5].
- Adulthood: Adults with MCADD must still avoid prolonged fasting. They need to be especially cautious with situations that cause missed meals, dehydration, or vomiting—such as severe illness, heavy exercise without fueling, or severe alcohol hangovers—as these significantly increase the risk of a metabolic crisis [5].
- Pregnancy: Women with MCADD can have healthy pregnancies. However, labor and delivery are periods of extreme physical exertion and potential metabolic stress, requiring close monitoring and often IV glucose to prevent decompensation during the process [7][5].
Routine Monitoring
While you will have regular check-ins with your metabolic specialist, “daily medicine” is rarely needed for MCADD.
- Metabolic Clinic: You will likely visit the metabolic clinic annually or bi-annually as your child gets older to review their growth and update their emergency protocols [3].
By maintaining a relationship with a metabolic team throughout your child’s life, you ensure they have the support needed to handle every milestone—from their first surgery to starting a family—safely and confidently [2][6].
Common questions in this guide
What is the long-term outlook for a child with MCADD?
How is surgery managed for someone with MCADD?
Can women with MCADD have healthy pregnancies?
What precautions do adults with MCADD need to take?
How often will my child need to visit the metabolic clinic?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.At what age should we begin the formal process of transitioning my child's care to an adult metabolic specialist?
- 2.How often will my child need blood work or clinic visits once they reach adolescence?
- 3.What specific precautions should my child take regarding alcohol or intense exercise as they get older?
- 4.How do we update the surgical protocol if my child needs a procedure at a hospital that isn't familiar with MCADD?
- 5.Are there any long-term health markers (like lipid levels or markers of oxidative stress) you monitor in your adult patients?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening.
Mütze U, Nennstiel U, Odenwald B, et al.
European journal of pediatrics 2022; (181(6)):2415-2422 doi:10.1007/s00431-022-04421-y.
PMID: 35294644 - 2
Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment.
Mason E, Hindmarch CCT, Dunham-Snary KJ
Endocrinology, diabetes & metabolism 2023; (6(1)):e385 doi:10.1002/edm2.385.
PMID: 36300606 - 3
Child Neurology: medium-chain acyl-coenzyme A dehydrogenase deficiency.
Gartner V, McGuire PJ, Lee PR
Neurology 2015; (85(4)):e37-40 doi:10.1212/WNL.0000000000001786.
PMID: 26215884 - 4
Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients.
Gong Z, Liang L, Qiu W, et al.
Frontiers in genetics 2021; (12()):577046 doi:10.3389/fgene.2021.577046.
PMID: 33841490 - 5
Coexistence of medium chain acyl-CoA dehydrogenase deficiency (MCADD) and type 1 diabetes (T1D): a management challenge.
Afreh-Mensah D, Agwu JC
BMJ case reports 2021; (14(3)) doi:10.1136/bcr-2020-239325.
PMID: 33762273 - 6
Lipidomic Profiling of Red Blood Cells in the Mitochondrial Fatty Acid β-oxidation Disorder MCADD Reveals Phospholipid and Sphingolipid Dysregulation.
Guerra IMS, Ferreira HB, Diogo L, et al.
Journal of proteome research 2025; (24(9)):4631-4642 doi:10.1021/acs.jproteome.5c00308.
PMID: 40704861 - 7
A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency.
Allen C, Perkins R, Schwahn B
Paediatric anaesthesia 2017; (27(1)):60-65 doi:10.1111/pan.13065.
PMID: 27896927 - 8
A Remimazolam and Remifentanil Anesthetic for a Pediatric Patient With a Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Case Report.
Kiyokawa M, Saito J, Nakai K, Hirota K
A&A practice 2022; (16(12)):e01646 doi:10.1213/XAA.0000000000001646.
PMID: 36599020 - 9
Successful perioperative management of a pediatric patient with medium-chain acyl-CoA dehydrogenase deficiency using a continuous tissue glucose monitoring device: A case report.
Hidekazu I, Shoji M
Saudi journal of anaesthesia 2021; (15(2)):213-215 doi:10.4103/sja.sja_1041_20.
PMID: 34188645
This page provides educational information about living with MCADD and surgical protocols. Always consult your metabolic specialist before any medical procedure, major lifestyle change, or when transitioning care.
Get notified when new evidence is published on Medium chain acyl-CoA dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.